Jazz Pharmaceuticals PLC (JAZZ)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 716,630 | 578,580 | 512,268 | 170,278 | 765,462 |
| Total assets | US$ in thousands | 12,012,300 | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 |
| Operating ROA | 5.97% | 5.08% | 4.73% | 1.38% | 11.71% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $716,630K ÷ $12,012,300K
= 5.97%
The operating return on assets (ROA) for Jazz Pharmaceuticals PLC has exhibited fluctuations over the years. The trend shows a decline from 11.71% as of December 31, 2020, to 1.38% as of December 31, 2021, indicating a significant decrease in the company's profitability relative to its asset base. However, there has been a gradual improvement in the operating ROA since then, with figures of 4.73% as of December 31, 2022, 5.08% as of December 31, 2023, and 5.97% as of December 31, 2024.
The varying operating ROA values suggest that Jazz Pharmaceuticals PLC may have experienced changes in its operational efficiency and asset utilization over the years. It is important for the company to continue monitoring and managing its operating ROA to ensure sustainable profitability and effective utilization of its assets for future growth and success.
Peer comparison
Dec 31, 2024